Get the Stockscreener App
0.002
5.26%
0.0001
Replicel Life Sciences Inc Stock (REPCF) Forecast
The Replicel Life Sciences Inc (REPCF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.0156, representing a +680.00% increase from the current price of $0.002. The highest analyst price target is $0.0269, and the lowest is $0.00433.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month REPCF Price Target
Average 0.0359
(+1,694% Upside)
Long-term REPCF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Replicel Life Sciences Inc financial reports and earnings history, Replicel Life Sciences Inc (REPCF) stock could reach $0.1129 by 2030, $0.326 by 2040 and $0.6051 by 2050. See the projected annual prices until 2050 of the Replicel Life Sciences Inc stock below:
- Replicel Life Sciences Inc (REPCF) is expected to reach an average price of $0.2256 in 2035, with a high prediction of $0.2332 and a low estimate of $0.2332. This indicates an $11,181% rise from the last recorded price of $0.002.
- Replicel Life Sciences Inc (REPCF) stock is projected to chart a bullish course in 2040, with an average price target of $0.3296, representing an $16,379% surge from its current level. The forecast ranges from a conservative $0.3242 to a sky-high $0.326.
- Our analysts predict Replicel Life Sciences Inc (REPCF) to jump 24,341% by 2045, soaring from $0.4907 to an average price of $0.4888, potentially reaching $0.5047. While $0.4907 is the low estimate, the potential upside is significant.
- Replicel Life Sciences Inc (REPCF) stock is expected to climb by 2050, reaching an average of $0.6047, a $30,137% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.6051 and $0.6047, respectively, highlighting the market's uncertainty.
Replicel Life Sciences Inc Stock (REPCF) Year by Year Forecast
Replicel Life Sciences Inc Stock (REPCF) Price Forecast for 2025
Replicel Life Sciences Inc Stock (REPCF) is expected to reach an average price of $0.0411 in 2025, with a high prediction of $0.0812 and a low estimate of $0.00094. This indicates an +1,953% rise from the last recorded price of $0.002.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $0.00433 | $0.00433 | $0.0269 | +116.46% |
| June, 2025 | $0.0158 | $0.00197 | $0.0707 | +692.09% |
| July, 2025 | $0.0355 | $0.00129 | $0.0355 | +1,674% |
| August, 2025 | $0.000783 | $0.00575 | $0.031 | -60.84% |
| September, 2025 | $0.00552 | $0.0046 | $0.0289 | +175.81% |
| October, 2025 | $0.00104 | $0.00347 | $0.00631 | -47.87% |
| November, 2025 | $0.0602 | $0.00544 | $0.0602 | +2,908% |
| December, 2025 | $0.009 | $0.00167 | $0.0297 | +350.10% |
Replicel Life Sciences Inc Stock (REPCF) Price Forecast for 2026
The predicted value for Replicel Life Sciences Inc (REPCF) in 2026 is set at an average of $0.0251. Estimates vary from a peak of $0.0497 to a trough of $0.000632, indicating an +1,157% surge from the present price of $0.002.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.0153 | $0.00108 | $0.0254 | +666.05% |
| February, 2026 | $0.00121 | $0.00398 | $0.0175 | -39.74% |
| March, 2026 | $0.0149 | $0.0144 | $0.0144 | +646.52% |
| April, 2026 | $0.00261 | $0.00261 | $0.00795 | +30.72% |
| May, 2026 | $0.0053 | $0.0053 | $0.0497 | +164.93% |
| June, 2026 | $0.0236 | $0.00847 | $0.0179 | +1,080% |
| July, 2026 | $0.0142 | $0.0154 | $0.0208 | +610.23% |
| August, 2026 | $0.0253 | $0.0179 | $0.0253 | +1,167% |
| September, 2026 | $0.00584 | $0.0267 | $0.0198 | +192.13% |
| October, 2026 | $0.0152 | $0.0132 | $0.0392 | +661.86% |
| November, 2026 | $0.00811 | $0.000632 | $0.0156 | +305.44% |
| December, 2026 | $0.0221 | $0.0267 | $0.0323 | +1,003% |
Replicel Life Sciences Inc Stock (REPCF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Replicel Life Sciences Inc (REPCF) is $0.0344, with a high forecast of $0.0582 and a low forecast of $0.0107. This indicates an +1,622% increase from the last price of $0.002.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0277 | $0.0274 | $0.0277 | +1,287% |
| February, 2027 | $0.0313 | $0.0363 | $0.0363 | +1,467% |
| March, 2027 | $0.0149 | $0.0238 | $0.0287 | +646.03% |
| April, 2027 | $0.0214 | $0.0259 | $0.0259 | +971.29% |
| May, 2027 | $0.045 | $0.0107 | $0.0438 | +2,150% |
| June, 2027 | $0.0364 | $0.0381 | $0.0368 | +1,721% |
| July, 2027 | $0.0475 | $0.0472 | $0.0472 | +2,276% |
| August, 2027 | $0.0182 | $0.0343 | $0.0403 | +807.56% |
| September, 2027 | $0.0436 | $0.0362 | $0.0362 | +2,078% |
| October, 2027 | $0.0584 | $0.0208 | $0.0527 | +2,819% |
| November, 2027 | $0.0461 | $0.0495 | $0.0553 | +2,206% |
| December, 2027 | $0.0582 | $0.0582 | $0.0582 | +2,808% |
Replicel Life Sciences Inc Stock (REPCF) Price Forecast for 2028
In 2028, Replicel Life Sciences Inc (REPCF) is projected to reach an average price of $0.0554, with a high projection of $0.08 and a low estimate of $0.0308. This indicates an +2,672% rise from the last price of $0.002.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0449 | $0.0449 | $0.0524 | +2,146% |
| February, 2028 | $0.0464 | $0.0464 | $0.0464 | +2,222% |
| March, 2028 | $0.0383 | $0.0308 | $0.0457 | +1,813% |
| April, 2028 | $0.0562 | $0.0608 | $0.0668 | +2,709% |
| May, 2028 | $0.0868 | $0.0613 | $0.061 | +4,242% |
| June, 2028 | $0.0794 | $0.0691 | $0.0691 | +3,869% |
| July, 2028 | $0.0567 | $0.0555 | $0.0567 | +2,734% |
| August, 2028 | $0.035 | $0.0409 | $0.0567 | +1,651% |
| September, 2028 | $0.0793 | $0.0611 | $0.0783 | +3,867% |
| October, 2028 | $0.0721 | $0.0722 | $0.0721 | +3,503% |
| November, 2028 | $0.0745 | $0.08 | $0.08 | +3,626% |
| December, 2028 | $0.0134 | $0.0661 | $0.0661 | +568.10% |
Replicel Life Sciences Inc Stock (REPCF) Price Forecast for 2029
The 2029 price forecast for Replicel Life Sciences Inc Stock (REPCF) is $0.0765 on average, with a high prediction of $0.1019 and a low estimate of $0.051. This represents an +3,723% increase from the previous price of $0.002.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.062 | $0.067 | $0.067 | +3,000% |
| February, 2029 | $0.0959 | $0.051 | $0.0899 | +4,697% |
| March, 2029 | $0.0798 | $0.0836 | $0.0857 | +3,890% |
| April, 2029 | $0.091 | $0.091 | $0.091 | +4,450% |
| May, 2029 | $0.0767 | $0.0767 | $0.0835 | +3,733% |
| June, 2029 | $0.0773 | $0.0773 | $0.0774 | +3,765% |
| July, 2029 | $0.1047 | $0.0611 | $0.099 | +5,137% |
| August, 2029 | $0.0933 | $0.095 | $0.1014 | +4,565% |
| September, 2029 | $0.1199 | $0.0965 | $0.0942 | +5,894% |
| October, 2029 | $0.0804 | $0.1013 | $0.1019 | +3,919% |
| November, 2029 | $0.0878 | $0.0872 | $0.0878 | +4,288% |
| December, 2029 | $0.0794 | $0.0711 | $0.0876 | +3,868% |
Replicel Life Sciences Inc Stock (REPCF) Price Forecast for 2030
Replicel Life Sciences Inc Stock (REPCF) is expected to reach an average price of $0.1086 in 2030, with a high forecast of $0.1359 and a low forecast of $0.0812. This signifies an +5,328% surge from the last price of $0.002.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.1017 | $0.1063 | $0.1129 | +4,984% |
| February, 2030 | $0.1053 | $0.1065 | $0.1053 | +5,166% |
| March, 2030 | $0.1069 | $0.1129 | $0.1129 | +5,245% |
| April, 2030 | $0.0879 | $0.0978 | $0.0978 | +4,297% |
| May, 2030 | $0.0924 | $0.0979 | $0.0981 | +4,521% |
| June, 2030 | $0.1305 | $0.0812 | $0.1244 | +6,425% |
| July, 2030 | $0.1145 | $0.1177 | $0.12 | +5,625% |
| August, 2030 | $0.1236 | $0.1238 | $0.1238 | +6,080% |
| September, 2030 | $0.0554 | $0.1084 | $0.1159 | +2,669% |
| October, 2030 | $0.1151 | $0.1082 | $0.1085 | +5,653% |
| November, 2030 | $0.1395 | $0.0913 | $0.1338 | +6,875% |
| December, 2030 | $0.1247 | $0.1291 | $0.1359 | +6,136% |
0.12%
0.08%
Cap:
|
Volume (24h):